Disease-cancelling drugs: Immuneering raises $62m in Series B round
Massachusetts-based Immuneering Corporation has closed an oversubscribed $62m Series B round. The financing was led by Cormorant Asset Management. Surveyor…
Massachusetts-based Immuneering Corporation has closed an oversubscribed $62m Series B round. The financing was led by Cormorant Asset Management. Surveyor…
2020 was a tough year for everyone, and the life sciences industry was no exception. The Covid-19 pandemic caused significant…
Ansa Biotechnologies has raised $7.9m as part of its oversubscribed seed financing round. Horizons Ventures led the financing round, with participation from Humboldt Fund, Mubadala…
On Wednesday 25 November, the UK’s Chancellor of the Exchequer Rishi Sunak travelled from Downing Street to the House of…
Pharma giant Merck has entered into a definitive agreement to acquire oncology biotech VelosBio for $2.75bn in cash. The acquisition…
Pre-filled syringes are regarded as one of the most effective medical devices of administering medications to patients. The rapidly increasing…
Cytiva opened a new facility for manufacturing Xcellerex XDR bioreactors in Shrewsbury, Massachusetts, US, in December 2020. The new manufacturing…
Last year, there was significant focus on the pharmaceutical industry as the race for Covid-19 treatments and vaccine began. With…
OpenClinica is pleased to announce that it will be featured on public television series In Depth, showcasing its clinical trials…